Literature DB >> 17157585

Longitudinal cohort study of patients with birdshot chorioretinopathy II: color vision at baseline.

Gary N Holland1, Kayur H Shah, Dominique Monnet, Antoine P Brezin, Fei Yu, Steven Nusinowitz, Ralph D Levinson.   

Abstract

PURPOSE: To describe color vision at the baseline examination of 80 participants in a longitudinal cohort study of birdshot chorioretinopathy and to identify relationships between color vision and visual acuity, symptoms, and ophthalmic signs.
DESIGN: Single center cross-sectional study.
METHODS: Color vision was evaluated with the desaturated Lanthony 15-Hue test. Relationships were sought between the square root of the color confusion scores (CCS) and the following factors: best-corrected visual acuity (BCVA), symptoms, cataract, vitreous inflammatory reactions, retinal vasculitis, cystoid macular edema (CME), and birdshot lesion characteristics.
RESULTS: When compared with published, age-matched normal control subjects, 49 patients (61.3%; 76 eyes [47.5%]) had abnormal CCS values. Abnormal CCS values were found in nine of 51 phakic eyes (18%) with normal BCVA (>or=1.0) and without cataract. Although most eyes did not have classifiable defects, 30 eyes (18.8%) had tritan (blue-yellow) defects (88% of eyes with classifiable defects). With the use of multivariate analyses, there were significant associations between increased CCS values and the symptoms of altered color vision (P = .005) and altered contrast sensitivity (P = .015). There was a significant, but weak, relationship between CCS values and birdshot lesion morphologic condition (P = .049), but no relationships were found with other lesion characteristics or with vitreous inflammatory reactions, retinal vasculitis, or CME.
CONCLUSION: The Lanthony 15-Hue test provides an objective technique to assess complaints of altered color vision in people with birdshot chorioretinopathy. Color vision can be abnormal in eyes with normal visual acuity; therefore, this parameter may be useful as an additional measure for monitoring the disease.

Entities:  

Mesh:

Year:  2006        PMID: 17157585     DOI: 10.1016/j.ajo.2006.06.065

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  2 in total

1.  Alterations of color vision and central visual field in patients with Vogt-Koyanagi-Harada syndrome.

Authors:  Peizeng Yang; Min Sun; Xiaoli Liu; Hongyan Zhou; Wang Fang; Li Wang; Aize Kijlstra
Journal:  J Ophthalmic Inflamm Infect       Date:  2012-02-02

Review 2.  Birdshot Chorioretinopathy: A Review.

Authors:  Elodie Bousquet; Pierre Duraffour; Louis Debillon; Swathi Somisetty; Dominique Monnet; Antoine P Brézin
Journal:  J Clin Med       Date:  2022-08-16       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.